The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 18, 2018
Filed:
Oct. 31, 2016
Applicant:
Elcelyx Therapeutics, Inc., San Diego, CA (US);
Inventors:
Alain D. Baron, San Diego, CA (US);
Mark S. Fineman, San Diego, CA (US);
Nigel R. A. Beeley, Solana Beach, CA (US);
Assignee:
ELCELYX THERAPEUTICS, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 3/10 (2006.01); C07C 279/26 (2006.01); A61K 9/22 (2006.01); A61K 31/155 (2006.01); A61K 45/06 (2006.01); A61K 31/341 (2006.01); A61K 31/36 (2006.01); A61K 31/381 (2006.01); A61K 31/40 (2006.01); A61K 31/53 (2006.01); A61K 31/4196 (2006.01); A61K 31/4453 (2006.01); A61K 31/454 (2006.01); A61K 31/55 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 9/28 (2006.01); A61K 31/137 (2006.01); A61K 31/35 (2006.01); A61K 31/485 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 9/2086 (2013.01); A61K 9/2806 (2013.01); A61K 9/4808 (2013.01); A61K 31/137 (2013.01); A61K 31/341 (2013.01); A61K 31/35 (2013.01); A61K 31/36 (2013.01); A61K 31/381 (2013.01); A61K 31/40 (2013.01); A61K 31/4196 (2013.01); A61K 31/4453 (2013.01); A61K 31/454 (2013.01); A61K 31/485 (2013.01); A61K 31/53 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01);
Abstract
Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.